These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 873421)

  • 1. [Experimental principles of immunotherapy in malignant tumors using microbial substances. 2. Effect of streptococci on ascites-rethotelsarcoma of the mouse in vitro].
    Huth E
    Fortschr Med; 1977 Jun; 95(21):1409-12. PubMed ID: 873421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental principles of immunotherapy using microbial substances in malignant tumors. 1. Effect of streptococci on ascite retothelsarcoma in the mouse in vitro].
    Huth E
    Fortschr Med; 1977 May; 95(20):1359-64. PubMed ID: 326651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antitumor action of bacterial extracts. II. Suppressive effects of extracts of E. coil on subcutaneous tumors of mouse.
    Watanabe T; Sakamoto I
    Jpn J Exp Med; 1982 Feb; 52(1):39-44. PubMed ID: 6752491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapy.
    Haranaka K; Sakurai A; Satomi N
    J Biol Response Mod; 1987 Aug; 6(4):379-91. PubMed ID: 3625230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain differences in the antitumor activity of an immunopotentiator, Nocardia rubra cell-wall skeleton, in B10 congenic and recombinant mice.
    Haraguchi S; Kurakata S; Matsuo T; Yoshida TO
    Jpn J Cancer Res; 1985 May; 76(5):400-13. PubMed ID: 2989065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots.
    Suzuki F; Schmitt DA; Utsunomiya T; Pollard RB
    In Vivo; 1992; 6(6):589-96. PubMed ID: 1296807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a bacterial vaccine on tumors and the immune response of ICR/Ha mice.
    Havas HF; Schiffman G; Bushnell B; Dellaria M; Axelrod RS; Shanahan T; Burns MM; Guan CF
    J Biol Response Mod; 1990 Apr; 9(2):194-204. PubMed ID: 2187952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priming of naive T cells inside tumors leads to eradication of established tumors.
    Yu P; Lee Y; Liu W; Chin RK; Wang J; Wang Y; Schietinger A; Philip M; Schreiber H; Fu YX
    Nat Immunol; 2004 Feb; 5(2):141-9. PubMed ID: 14704792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types.
    Papa MZ; Mulé JJ; Rosenberg SA
    Cancer Res; 1986 Oct; 46(10):4973-8. PubMed ID: 3489517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunological basis of tumor rejection: the absolute dependence of the effector arm on sensitized T cells after chemoimmunotherapy of a murine sarcoma.
    Evans R; Duffy T
    J Immunol; 1985 Jun; 134(6):4255-60. PubMed ID: 3872913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytotoxic activity in mouse tumors by lymphocytes with anti-streptococcal specific antibodies].
    Fujioka T; Tanji S; Koike H; Kumagai K; Aoki H; Kubo T; Ohhori T
    Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1243-7. PubMed ID: 3068321
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement of the anti-tumor efficacy of a GM-CSF-secreting tumor cell immunotherapy in preclinical models by cytosine arabinoside.
    Lin JM; Li B; Rimmer E; VanRoey M; Jooss K
    Exp Hematol; 2008 Mar; 36(3):319-28. PubMed ID: 18279719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens.
    Kahan BD; Tanaka T; Pellis NR
    J Natl Cancer Inst; 1980 Nov; 65(5):1001-4. PubMed ID: 6159495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antitumor action of bacterial extract. I. Suppression of mouse ascites tumors by the treatments with extracts of E. coli.
    Watanabe T
    Jpn J Exp Med; 1969 Dec; 39(6):631-47. PubMed ID: 4914751
    [No Abstract]   [Full Text] [Related]  

  • 15. IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice.
    Yim JH; Wu SJ; Casey MJ; Norton JA; Doherty GM
    J Immunol; 1997 Feb; 158(3):1284-92. PubMed ID: 9013971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An approach for the generation of effector lymphocytes from tumor-bearing hosts for the adoptive immunotherapy of established tumors.
    Shu SY; Chou T
    Prog Clin Biol Res; 1987; 244():27-37. PubMed ID: 3498953
    [No Abstract]   [Full Text] [Related]  

  • 17. Adoptive immunotherapy of newly induced murine sarcomas.
    Shu SY; Rosenberg SA
    Cancer Res; 1985 Apr; 45(4):1657-62. PubMed ID: 3872168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of transplantation tumors of mice with phosphazine (phosphamide) in combination with roentgen irradiation].
    Ivanova LA
    Patol Fiziol Eksp Ter; 1968; 12(4):60-1. PubMed ID: 5747003
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ; Farha M; Loftus A; Elias EG
    J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of tumor-bearing mice with chemically modified tumor membrane fractions of two syngeneic tumor cell lines.
    Staab HJ; Anderer FA
    Cancer Detect Prev; 1984; 7(4):279-88. PubMed ID: 6091881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.